Literature DB >> 12402983

Body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women with similar BMI.

Nese Ozbey1, Ergin Sencer, Senay Molvalilar, Yusuf Orhan.   

Abstract

The aim of this study is to determine the body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women matched for weight, height and body mass index (BMI). Study group consisted of 405 premenopausal overweight/obese (BMI > 27 kg/m2, mean 37.83 +/- 6.91 kg/m2) and 405 postmenopausal overweight/obese (BMI > 27 kg/m2), BMI-matched (mean 37.77 +/- 6.84 kg/m2) women. None of the women were on hormone replacement therapy. Insulin resistance was evaluated by "homeostasis model assessment" (HOMA) formula. Intraabdominal fat volume was calculated according to the following formula: IAF (L) = [(0.370 x abdominal sagittal diameter) - 4.85]. Age, waist circumference, waist to hip ratio (WHR) and intraabdominal fat volume were significantly higher in postmenopausals compared with BMI-matched premenopausal women (p < 0.001). Systolic and diastolic blood pressure, glucose, uric acid, cholesterol and triglyceride were significantly higher (p < 0.001) and HDL-cholesterol was significantly lower (p < 0.05) in postmenopausals. No significant differences were observed with respect to insulin and HOMA. When age-matched pre- and postmenopausal women were compared, only total cholesterol was significantly higher in the postmenopausal group. However, older postmenopausal women (> 50 years) had significantly higher systolic blood pressure, waist circumference, WHR, glucose and uric acid concentrations compared with younger (< or = 50 years) postmenopausals. It is concluded that an increase in abdominal fat accumulation and unfavorable alterations in risk factors disturb postmenopausal obese women even if total body weight and BMI do not change during menopause transition. Ageing, particularly throughout the postmenopausal years, has important effects on the detrimental changes associated with menopause.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402983     DOI: 10.1507/endocrj.49.503

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  17 in total

Review 1.  Metabolic syndrome, androgens, and hypertension.

Authors:  Mohadetheh Moulana; Roberta Lima; Jane F Reckelhoff
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

2.  Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause.

Authors:  A Tufano; P Marzo; R Enrini; L Morricone; F Caviezel; B Ambrosi
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

Review 3.  Hypertension in postmenopausal women.

Authors:  Roberta Lima; Marion Wofford; Jane F Reckelhoff
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

4.  Estrogen deficiency after menopause does not result in male very-low-density lipoprotein metabolism phenotype.

Authors:  Faidon Magkos; Elisa Fabbrini; B Selma Mohammed; Bruce W Patterson; Samuel Klein; Bettina Mittendorfer
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

Review 5.  Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association.

Authors:  Jean C McSweeney; Anne G Rosenfeld; Willie M Abel; Lynne T Braun; Lora E Burke; Stacie L Daugherty; Gerald F Fletcher; Martha Gulati; Laxmi S Mehta; Christina Pettey; Jane F Reckelhoff
Journal:  Circulation       Date:  2016-02-29       Impact factor: 29.690

6.  Appetitive hormones, but not isoflavone tablets, influence overall and central adiposity in healthy postmenopausal women.

Authors:  Oksana A Matvienko; D Lee Alekel; Ulrike Genschel; Laura Ritland; Marta D Van Loan; Kenneth J Koehler
Journal:  Menopause       Date:  2010 May-Jun       Impact factor: 2.953

7.  Intestinal nerve cell injury occurs prior to insulin resistance in female mice ingesting a high-fat diet.

Authors:  Yvonne Nyavor; Rachel Estill; Hannah Edwards; Hailey Ogden; Kaila Heideman; Kiefer Starks; Christopher Miller; George May; Lance Flesch; John McMillan; Martin Gericke; Larry Forney; Onesmo Balemba
Journal:  Cell Tissue Res       Date:  2019-02-18       Impact factor: 5.249

8.  Hypothalamic PGC-1α protects against high-fat diet exposure by regulating ERα.

Authors:  Eugenia Morselli; Esther Fuente-Martin; Brian Finan; Min Kim; Aaron Frank; Cristina Garcia-Caceres; Carlos Rodriguez Navas; Ruth Gordillo; Michael Neinast; Sarada P Kalainayakan; Dan L Li; Yuanqing Gao; Chun-Xia Yi; Lisa Hahner; Biff F Palmer; Matthias H Tschöp; Deborah J Clegg
Journal:  Cell Rep       Date:  2014-10-16       Impact factor: 9.423

Review 9.  Postmenopausal hypertension.

Authors:  Licy L Yanes; Jane F Reckelhoff
Journal:  Am J Hypertens       Date:  2011-04-21       Impact factor: 2.689

10.  Age of natural menopause and atrial fibrillation: the Framingham Heart Study.

Authors:  Jared W Magnani; Carlee B Moser; Joanne M Murabito; Kerrie P Nelson; Joao D Fontes; Steven A Lubitz; Lisa M Sullivan; Patrick T Ellinor; Emelia J Benjamin
Journal:  Am Heart J       Date:  2012-03-29       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.